Home Cart 0 Sign in  

[ CAS No. 42882-31-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 42882-31-5
Chemical Structure| 42882-31-5
Structure of 42882-31-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 42882-31-5 ]

Related Doc. of [ 42882-31-5 ]

Alternatived Products of [ 42882-31-5 ]

Product Details of [ 42882-31-5 ]

CAS No. :42882-31-5 MDL No. :MFCD00004014
Formula : C12H13N Boiling Point : -
Linear Structure Formula :- InChI Key :RTCUCQWIICFPOD-UHFFFAOYSA-N
M.W : 171.24 Pubchem ID :98089
Synonyms :

Calculated chemistry of [ 42882-31-5 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 56.43
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.06
Log Po/w (XLOGP3) : 2.76
Log Po/w (WLOGP) : 2.54
Log Po/w (MLOGP) : 2.85
Log Po/w (SILICOS-IT) : 2.77
Consensus Log Po/w : 2.59

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.123 mg/ml ; 0.000718 mol/l
Class : Soluble
Log S (Ali) : -2.96
Solubility : 0.187 mg/ml ; 0.00109 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.14
Solubility : 0.0123 mg/ml ; 0.0000718 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.12

Safety of [ 42882-31-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 42882-31-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 42882-31-5 ]
  • Downstream synthetic route of [ 42882-31-5 ]

[ 42882-31-5 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 941-98-0 ]
  • [ 42882-31-5 ]
YieldReaction ConditionsOperation in experiment
40% With hydroxylamine hydrochloride; ammonium formate; zinc In methanol for 5 h; Reflux The corresponding ketone (10 mmol: 1.14 g of 1a, 0.98 g of 1b, 1.48 g of 1c, 1.46 g of1d, 1.46 g of 1e, 1.32 g of 1f, 1.20 g of 1g, 1.70 g of 1h, 1.70 g of 1i), hydroxylamine hydrochloride (15mmol, 1.04 g), ammonium formate (60 mmol, 3.78 g) and Zn powder (30 mmol, 1.96 g) in methanol (30mL) was stirred under reflux. After completion of the reaction the mixture was filtered through Celite.(R). andthe solvent was removed by vacuum rotary evaporation. The residue was treated with conc. HCl solution (4mL) and water (30 mL), and then extracted with diethyl ether (2x20 mL) to remove organic residues. Theaqueous phase was alkalized with ammonia solution to pH=10 and extracted with dichloromethane (4x25mL). The organic phase was washed with brine, dried over sodium sulfate and the solvent removed undervacuum.
Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 12, p. 1310 - 1312
[2] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6197 - 6208
[3] Patent: WO2008/58235, 2008, A2, . Location in patent: Page/Page column 23-24
[4] Synthetic Communications, 2011, vol. 41, # 3, p. 341 - 346
[5] Molecules, 2014, vol. 19, # 12, p. 21386 - 21397
[6] European Journal of Organic Chemistry, 2015, vol. 2015, # 24, p. 5393 - 5401
  • 2
  • [ 344248-49-3 ]
  • [ 42882-31-5 ]
YieldReaction ConditionsOperation in experiment
80% With hydrogenchloride In ethanol at 20℃; for 2 h; Gaseous hydrogen chloride was bubbled through a stirred solution of N-diphenylphosphinyl-1-naphthylethylamine in ethyl alcohol for 2 hours at room temperature. The reaction mixture was concentrated, made basic by the addition of an aqueous solution of sodium hydroxide (2 M) and extracted with dichloromethane (3.x.10 ml). The organic layer was washed with brine (1.x.10 ml), dried over magnesium sulphate and concentrated to give the product as a yellow liquid in 80percent yield.
Reference: [1] Patent: US6696608, 2004, B1, . Location in patent: Page column 28
  • 3
  • [ 1956-40-7 ]
  • [ 42882-31-5 ]
Reference: [1] Synthetic Communications, 2011, vol. 41, # 3, p. 341 - 346
[2] Tetrahedron, 1994, vol. 50, # 34, p. 10309 - 10320
  • 4
  • [ 10420-89-0 ]
  • [ 946113-79-7 ]
  • [ 42882-31-5 ]
Reference: [1] Advanced Synthesis and Catalysis, 2008, vol. 350, # 1, p. 113 - 121
  • 5
  • [ 3886-70-2 ]
  • [ 42882-31-5 ]
Reference: [1] Patent: US2013/345475, 2013, A1, . Location in patent: Paragraph 0117
  • 6
  • [ 3886-70-2 ]
  • [ 1127-76-0 ]
  • [ 42882-31-5 ]
Reference: [1] Patent: US2013/345475, 2013, A1, . Location in patent: Paragraph 0116
  • 7
  • [ 49681-33-6 ]
  • [ 42882-31-5 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 6, p. 1469 - 1472
  • 8
  • [ 75-31-0 ]
  • [ 42882-31-5 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 16, p. 3804 - 3809
  • 9
  • [ 42882-31-5 ]
  • [ 178306-51-9 ]
  • [ 178306-52-0 ]
Reference: [1] Patent: US2014/256004, 2014, A1, . Location in patent: Page/Page column
Same Skeleton Products
Historical Records